|
Feb 16
|
Prothena (PRTA) Q4 Earnings Miss Estimates on Higher R&D Expense
|
|
Feb 16
|
Prothena Corporation plc (NASDAQ:PRTA) Q4 2023 Earnings Call Transcript
|
|
Feb 15
|
Prothena Corp PLC (PRTA) Reports 2023 Financial Results and Provides 2024 Outlook
|
|
Feb 15
|
Prothena Reports Fourth Quarter and Full Year 2023 Financial Results, and Provides Financial Guidance and Business Highlights
|
|
Jan 10
|
Prothena's (PRTA) Update on Pipeline Progress Disappoints
|
|
Jan 10
|
Prothena (PRTA) Surges 12.3%: Is This an Indication of Further Gains?
|
|
Jan 8
|
Prothena Provides Updates on PRX012, PRX123, Birtamimab and Portfolio Programs
|
|
Dec 21
|
Prothena Corp PLC Chief Accounting Officer Sells Company Shares
|
|
Dec 8
|
Ligand (LGND) Up 12.4% Since Last Earnings Report: Can It Continue?
|
|
Dec 3
|
Prothena (NASDAQ:PRTA) shareholder returns have been strong, earning 207% in 5 years
|
|
Dec 1
|
Insider Sell Alert: Karin Walker of Prothena Corp PLC Cashes Out 5,000 Shares
|
|
Aug 4
|
Prothena (PRTA) Q2 Earnings and Revenues Miss Estimates
|
|
Aug 3
|
Prothena (PRTA) Reports Q2 Loss, Lags Revenue Estimates
|
|
Aug 3
|
Prothena Reports Second Quarter 2023 Financial Results and Business Highlights
|
|
Aug 2
|
Prothena Corporation plc (NASDAQ:PRTA) Shares Could Be 36% Below Their Intrinsic Value Estimate
|
|
Apr 27
|
Prothena to Report First Quarter 2023 Financial Results on May 4
|
|
Apr 27
|
Analysts Estimate Prothena (PRTA) to Report a Decline in Earnings: What to Look Out for
|